Maynard Um
-
-
-
-
-
-
-
Beyond Air comments on review article about high-dose nitric oxide therapy
-
-
-
-
-
-
-
Beyond Air, Inc. (XAIR) Misses Q2 EPS by 116c
-
-
-
-
-
-
-
Beyond Air wins Premier group purchasing agreement for therapeutic gases
-
-
-
-
-
-
-
BTIG Reiterates Neutral Rating on Beyond Air (XAIR)
-
-
-
-
-
-
-
Beyond Air, Inc. (XAIR) Reports In-Line Q2 EPS
-
-
-
-
-
-
-
Beyond Air (XAIR) PT Lowered to $1 at Piper Sandler
-
-
-
-
437,277 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

